Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris

Last updated: February 16, 2021
Sponsor: Galderma R&D
Overall Status: Completed

Phase

3

Condition

Acne

Inflammatory Comedones

Rash

Treatment

N/A

Clinical Study ID

NCT00883233
RD.03.SPR.29085
  • Ages 12-35
  • All Genders

Study Summary

The purpose of this study is to compare the tolerability of 3 treatment regimens containing Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel with that of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard daily overnight application for 12 weeks in the treatment of acne vulgaris. The efficacy of the four treatment regimens will also be evaluated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female Subjects of any race, aged 12 to 35 years inclusive
  • Subjects with mild or moderate facial acne vulgaris
  • Subjects with skin phototype I to IV

Exclusion

Exclusion Criteria:

  • Subjects with more than 1 nodules or cysts on the face,
  • Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-inducedacne, etc.)

Study Design

Total Participants: 123
Study Start date:
April 01, 2009
Estimated Completion Date:
September 30, 2009

Connect with a study center

  • Galderma Investigational Site

    Windsor, Ontario
    Canada

    Site Not Available

  • Galderma Investigational Site

    Montreal, Quebec
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.